$VION Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VION PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VION PHARMACEUTICALS INC. Get notifications about new insider transactions in VION PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 10 2009 | VION | VION PHARMACEUTICA ... | Cahill Ann Lee | VP Clinical Develop ... | Sell | S | 0.78 | 70,000 | 54,404 | 2,072 | 72.1 K to 2.1 K (-97.13 %) |
Sep 10 2009 | VION | VION PHARMACEUTICA ... | KING IVAN | VP Research and Dev ... | Sell | S | 1.09 | 45,166 | 49,353 | 1,307 | 46.5 K to 1.3 K (-97.19 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 1,130 | 0 | 9,683 | 8.6 K to 9.7 K (+13.21 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | Lewis Tanya | VP Regulatory and Q ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Grant | A | 0.00 | 1,130 | 0 | 33,971 | 32.8 K to 34 K (+3.44 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | RAKIN KEVIN | Director | Grant | A | 0.00 | 1,130 | 0 | 7,229 | 6.1 K to 7.2 K (+18.53 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | SARTORELLI ALAN | Director | Grant | A | 0.00 | 1,130 | 0 | 25,615 | 24.5 K to 25.6 K (+4.62 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | Williams Ian | Director | Grant | A | 0.00 | 1,130 | 0 | 6,229 | 5.1 K to 6.2 K (+22.16 %) |
Dec 12 2008 | VION | VION PHARMACEUTICA ... | WILLIS GARY K | Director | Grant | A | 0.00 | 1,130 | 0 | 9,683 | 8.6 K to 9.7 K (+13.21 %) |
Apr 03 2008 | VION | VION PHARMACEUTICA ... | Hahne William | VP Medical | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Oct 29 2007 | VION | VION PHARMACEUTICA ... | Ryan Aileen | VP Regulatory Affai ... | Buy | P | 1.68 | 1,500 | 2,520 | 381,500 | 380 K to 381.5 K (+0.39 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 11,300 | 0 | 85,535 | 74.2 K to 85.5 K (+15.22 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | CARTER STEPHEN | Director | Grant | A | 0.00 | 11,300 | 0 | 35,535 | 24.2 K to 35.5 K (+46.63 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Grant | A | 0.00 | 11,300 | 0 | 328,422 | 317.1 K to 328.4 K (+3.56 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | RAKIN KEVIN | Director | Grant | A | 0.00 | 11,300 | 0 | 61,000 | 49.7 K to 61 K (+22.74 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | SARTORELLI ALAN | Director | Grant | A | 0.00 | 11,300 | 0 | 244,866 | 233.6 K to 244.9 K (+4.84 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | Williams Ian | Director | Grant | A | 0.00 | 11,300 | 0 | 51,000 | 39.7 K to 51 K (+28.46 %) |
Jun 28 2007 | VION | VION PHARMACEUTICA ... | WILLIS GARY K | Director | Grant | A | 0.00 | 11,300 | 0 | 85,535 | 74.2 K to 85.5 K (+15.22 %) |
Apr 11 2007 | VION | VION PHARMACEUTICA ... | Tanguay James | VP of Chem Manuf & ... | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.75 | 13,900 | 24,325 | 74,235 | 60.3 K to 74.2 K (+23.04 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.74 | 6,600 | 11,484 | 60,335 | 53.7 K to 60.3 K (+12.28 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.76 | 19,500 | 34,320 | 53,735 | 34.2 K to 53.7 K (+56.96 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Buy | P | 1.77 | 10,000 | 17,700 | 34,235 | 24.2 K to 34.2 K (+41.26 %) |
Mar 15 2007 | VION | VION PHARMACEUTICA ... | RAKIN KEVIN | Director | Buy | P | 1.59 | 15,000 | 23,850 | 49,700 | 34.7 K to 49.7 K (+43.23 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | KESSMAN ALAN | Chief Executive Off ... | Grant | A | 0.00 | 120,000 | 0 | 1,843,767 | 1.7 M to 1.8 M (+6.96 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | JOHNSON HOWARD B | President and CFO | Grant | A | 0.00 | 50,000 | 0 | 856,467 | 806.5 K to 856.5 K (+6.20 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Cahill Ann Lee | VP Clinical Develop ... | Grant | A | 0.00 | 50,000 | 0 | 720,720 | 670.7 K to 720.7 K (+7.45 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | KING IVAN | VP Research and Dev ... | Grant | A | 0.00 | 35,000 | 0 | 462,735 | 427.7 K to 462.7 K (+8.18 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Fitzgerald Meghan | VP and Chief Busine ... | Grant | A | 0.00 | 35,000 | 0 | 555,000 | 520 K to 555 K (+6.73 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | Ryan Aileen | VP Regulatory Affai ... | Grant | A | 0.00 | 100,000 | 0 | 380,000 | 280 K to 380 K (+35.71 %) |
Mar 14 2007 | VION | VION PHARMACEUTICA ... | SCHMEDLIN KAREN | VP Finance and CAO | Grant | A | 0.00 | 25,000 | 0 | 287,954 | 263 K to 288 K (+9.51 %) |
Mar 13 2007 | VION | VION PHARMACEUTICA ... | Williams Ian | Director | Buy | P | 1.66 | 5,000 | 8,300 | 39,700 | 34.7 K to 39.7 K (+14.41 %) |
Mar 09 2007 | VION | VION PHARMACEUTICA ... | WILLIS GARY K | Director | Buy | P | 1.52 | 50,000 | 76,000 | 74,235 | 24.2 K to 74.2 K (+206.31 %) |
Mar 09 2007 | VION | VION PHARMACEUTICA ... | KESSMAN ALAN | Chief Executive Off ... | Buy | P | 1.55 | 16,000 | 24,837 | 1,723,767 | 1.7 M to 1.7 M (+0.94 %) |
Mar 09 2007 | VION | VION PHARMACEUTICA ... | JOHNSON HOWARD B | President and CFO | Buy | P | 1.55 | 12,800 | 19,899 | 806,467 | 793.7 K to 806.5 K (+1.61 %) |
Jan 17 2007 | VION | VION PHARMACEUTICA ... | RAKIN KEVIN | Director | Grant | A | 0.00 | 34,700 | 0 | 34,700 | 0 to 34.7 K |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | Cahill Ann Lee | VP Clinical Develop ... | Grant | A | 0.00 | 480,000 | 0 | 670,720 | 190.7 K to 670.7 K (+251.68 %) |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | Ryan Aileen | VP Regulatory Affai ... | Grant | A | 0.00 | 186,667 | 0 | 280,000 | 93.3 K to 280 K (+200.00 %) |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | Fitzgerald Meghan | VP and Chief Busine ... | Grant | A | 0.00 | 360,000 | 0 | 520,000 | 160 K to 520 K (+225.00 %) |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | JOHNSON HOWARD B | President and CFO | Grant | A | 0.00 | 570,000 | 0 | 791,667 | 221.7 K to 791.7 K (+257.14 %) |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | KESSMAN ALAN | Chief Executive Off ... | Grant | A | 0.00 | 1,200,000 | 0 | 1,705,767 | 505.8 K to 1.7 M (+237.26 %) |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | KING IVAN | VP Research and Dev ... | Grant | A | 0.00 | 277,778 | 0 | 426,167 | 148.4 K to 426.2 K (+187.20 %) |
Dec 15 2006 | VION | VION PHARMACEUTICA ... | SCHMEDLIN KAREN | VP Finance and CAO | Grant | A | 0.00 | 166,666 | 0 | 260,954 | 94.3 K to 261 K (+176.76 %) |
Jul 18 2006 | VION | VION PHARMACEUTICA ... | Ryan Aileen | VP Regulatory Affai ... | Grant | A | 0.00 | 93,333 | 0 | 93,333 | 0 to 93.3 K |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | Williams Ian | Director | Grant | A | 0.00 | 34,700 | 0 | 34,700 | 0 to 34.7 K |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 11,300 | 0 | 24,235 | 12.9 K to 24.2 K (+87.36 %) |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | CARTER STEPHEN | Director | Grant | A | 0.00 | 11,300 | 0 | 24,235 | 12.9 K to 24.2 K (+87.36 %) |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Grant | A | 0.00 | 11,300 | 0 | 317,122 | 305.8 K to 317.1 K (+3.69 %) |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | SARTORELLI ALAN | Director | Grant | A | 0.00 | 11,300 | 0 | 233,566 | 222.3 K to 233.6 K (+5.08 %) |
Jun 28 2006 | VION | VION PHARMACEUTICA ... | WILLIS GARY K | Director | Grant | A | 0.00 | 11,300 | 0 | 24,235 | 12.9 K to 24.2 K (+87.36 %) |
Jan 11 2006 | VION | VION PHARMACEUTICA ... | Fitzgerald Meghan | VP and Chief Busine ... | Grant | A | 0.00 | 140,000 | 0 | 160,000 | 20 K to 160 K (+700.00 %) |
Jan 11 2006 | VION | VION PHARMACEUTICA ... | Fitzgerald Meghan | VP and Chief Busine ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jan 09 2006 | VION | VION PHARMACEUTICA ... | Cahill Ann Lee | VP Clinical Develop ... | Grant | A | 0.00 | 186,667 | 0 | 190,720 | 4.1 K to 190.7 K (+4,605.65 %) |
Jan 09 2006 | VION | VION PHARMACEUTICA ... | KING IVAN | VP Research and Dev ... | Grant | A | 0.00 | 138,889 | 0 | 148,389 | 9.5 K to 148.4 K (+1,461.99 %) |
Jan 09 2006 | VION | VION PHARMACEUTICA ... | JOHNSON HOWARD B | President and CFO | Grant | A | 0.00 | 221,667 | 0 | 221,667 | 0 to 221.7 K |
Jan 09 2006 | VION | VION PHARMACEUTICA ... | KESSMAN ALAN | Chief Executive Off ... | Grant | A | 0.00 | 466,667 | 0 | 503,767 | 37.1 K to 503.8 K (+1,257.86 %) |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Grant | A | 0.00 | 12,935 | 0 | 12,935 | 0 to 12.9 K |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | CARTER STEPHEN | Director | Grant | A | 0.00 | 12,935 | 0 | 12,935 | 0 to 12.9 K |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Grant | A | 0.00 | 12,935 | 0 | 305,822 | 292.9 K to 305.8 K (+4.42 %) |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | SARTORELLI ALAN | Director | Grant | A | 0.00 | 12,935 | 0 | 222,266 | 209.3 K to 222.3 K (+6.18 %) |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Grant | A | 0.00 | 12,935 | 0 | 17,935 | 5 K to 17.9 K (+258.70 %) |
Nov 18 2005 | VION | VION PHARMACEUTICA ... | WILLIS GARY K | Director | Grant | A | 0.00 | 12,935 | 0 | 12,935 | 0 to 12.9 K |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 1.57 | 20,000 | 31,400 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 1.67 | 7,242 | 12,094 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 0.36 | 11,111 | 4,000 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 0.55 | 8,696 | 4,783 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 0.43 | 23,529 | 10,117 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 0.77 | 20,000 | 15,400 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Option Exercise | M | 0.78 | 12,903 | 10,064 | 0 | |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 1.57 | 20,000 | 31,400 | 292,887 | 272.9 K to 292.9 K (+7.33 %) |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 1.67 | 7,242 | 12,094 | 272,887 | 265.6 K to 272.9 K (+2.73 %) |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 0.36 | 11,111 | 4,000 | 265,645 | 254.5 K to 265.6 K (+4.37 %) |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 0.55 | 8,696 | 4,783 | 254,534 | 245.8 K to 254.5 K (+3.54 %) |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 0.43 | 23,529 | 10,117 | 245,838 | 222.3 K to 245.8 K (+10.58 %) |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 0.77 | 20,000 | 15,400 | 222,309 | 202.3 K to 222.3 K (+9.89 %) |
Nov 17 2005 | VION | VION PHARMACEUTICA ... | MILLER WILLIAM R | Director | Buy | M | 0.78 | 12,903 | 10,064 | 202,309 | 189.4 K to 202.3 K (+6.81 %) |
Sep 14 2005 | VION | VION PHARMACEUTICA ... | KESSMAN ALAN | Chief Executive Off ... | Sell | S | 2.82 | 791 | 2,229 | 35,100 | 35.9 K to 35.1 K (-2.20 %) |
Jun 09 2005 | VION | VION PHARMACEUTICA ... | WILLIS GARY K | Director | Option Exercise | A | 2.09 | 20,000 | 41,800 | 20,000 | |
Jun 09 2005 | VION | VION PHARMACEUTICA ... | Bickerstaff George | Director | Option Exercise | A | 2.09 | 20,000 | 41,800 | 20,000 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 1.57 | 15,000 | 23,550 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 1.67 | 1,207 | 2,016 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 0.36 | 2,778 | 1,000 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 0.55 | 2,174 | 1,196 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 0.43 | 5,882 | 2,529 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 0.77 | 15,000 | 11,550 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Option Exercise | M | 0.78 | 3,226 | 2,516 | 0 | |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 1.57 | 15,000 | 23,550 | 107,985 | 93 K to 108 K (+16.13 %) |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 1.67 | 1,207 | 2,016 | 92,985 | 91.8 K to 93 K (+1.32 %) |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 0.36 | 2,778 | 1,000 | 91,778 | 89 K to 91.8 K (+3.12 %) |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 0.55 | 2,174 | 1,196 | 89,000 | 86.8 K to 89 K (+2.50 %) |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 0.43 | 5,882 | 2,529 | 86,826 | 80.9 K to 86.8 K (+7.27 %) |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 0.77 | 15,000 | 11,550 | 80,944 | 65.9 K to 80.9 K (+22.75 %) |
May 17 2005 | VION | VION PHARMACEUTICA ... | CARY FRANK T | Director | Buy | M | 0.78 | 3,226 | 2,516 | 65,944 | 62.7 K to 65.9 K (+5.14 %) |
Dec 10 2004 | VION | VION PHARMACEUTICA ... | JOHNSON HOWARD B | President and CFO | Option Exercise | A | 4.70 | 100,000 | 470,000 | 100,000 | |
Dec 10 2004 | VION | VION PHARMACEUTICA ... | KESSMAN ALAN | Chief Executive Off ... | Option Exercise | A | 4.70 | 150,000 | 705,000 | 150,000 | |
Dec 10 2004 | VION | VION PHARMACEUTICA ... | Cahill Ann Lee | VP Clinical Develop ... | Option Exercise | A | 4.70 | 50,000 | 235,000 | 50,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | A | 4.31 | 20,000 | 86,200 | 20,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | A | 4.75 | 11,317 | 53,756 | 11,317 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | D | 4.75 | 11,317 | 53,756 | 0 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | A | 4.75 | 45,000 | 213,750 | 45,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | D | 4.75 | 45,000 | 213,750 | 0 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | A | 7.38 | 65,000 | 479,375 | 65,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | D | 7.38 | 65,000 | 479,375 | 0 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | A | 14.88 | 75,000 | 1,115,625 | 75,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | D | 14.88 | 75,000 | 1,115,625 | 0 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | A | 5.06 | 122,000 | 617,686 | 122,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | SZNOL MARIO | Director | Option Exercise | D | 5.06 | 122,000 | 617,686 | 0 | |
Dec 10 2004 | VION | VION PHARMACEUTICA ... | KING IVAN | VP Research and Dev ... | Option Exercise | A | 4.70 | 50,000 | 235,000 | 50,000 | |
Oct 18 2004 | VION | VION PHARMACEUTICA ... | Cahill Ann Lee | V.P., Clinical Deve ... | Option Exercise | A | 4.31 | 55,000 | 237,050 | 55,000 | |
Sep 13 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.88 | 12,500 | 48,500 | 0 | 12.5 K to 0 (-100.00 %) |
Sep 13 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.86 | 19,221 | 74,193 | 12,500 | 31.7 K to 12.5 K (-60.59 %) |
Sep 13 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.88 | 12,500 | 48,500 | 0 | 12.5 K to 0 (-100.00 %) |
Sep 13 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.86 | 19,221 | 74,193 | 12,500 | 31.7 K to 12.5 K (-60.59 %) |
Sep 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.88 | 12,250 | 47,530 | 31,721 | 44 K to 31.7 K (-27.86 %) |
Sep 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.89 | 25,000 | 97,250 | 43,971 | 69 K to 44 K (-36.25 %) |
Sep 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.90 | 5,000 | 19,500 | 68,971 | 74 K to 69 K (-6.76 %) |
Sep 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.85 | 48,971 | 188,538 | 73,971 | 122.9 K to 74 K (-39.83 %) |
Sep 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.88 | 12,250 | 47,530 | 31,721 | 44 K to 31.7 K (-27.86 %) |
Sep 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.89 | 25,000 | 97,250 | 43,971 | 69 K to 44 K (-36.25 %) |
Sep 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.90 | 5,000 | 19,500 | 68,971 | 74 K to 69 K (-6.76 %) |
Sep 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.85 | 26,029 | 100,212 | 73,971 | 100 K to 74 K (-26.03 %) |
Sep 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.93 | 18,000 | 70,740 | 100,000 | 118 K to 100 K (-15.25 %) |
Sep 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 4.00 | 1,581 | 6,324 | 118,000 | 119.6 K to 118 K (-1.32 %) |
Sep 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.93 | 12,000 | 47,160 | 122,942 | 134.9 K to 122.9 K (-8.89 %) |
Sep 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.00 | 11,519 | 46,076 | 134,942 | 146.5 K to 134.9 K (-7.86 %) |
Sep 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.74 | 15,000 | 56,100 | 119,581 | 134.6 K to 119.6 K (-11.15 %) |
Sep 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.88 | 90,120 | 349,666 | 134,581 | 224.7 K to 134.6 K (-40.11 %) |
Sep 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.70 | 15,000 | 55,500 | 224,701 | 239.7 K to 224.7 K (-6.26 %) |
Sep 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.69 | 15,000 | 55,350 | 239,701 | 254.7 K to 239.7 K (-5.89 %) |
Sep 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.74 | 10,000 | 37,400 | 146,461 | 156.5 K to 146.5 K (-6.39 %) |
Sep 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.88 | 60,080 | 233,110 | 156,461 | 216.5 K to 156.5 K (-27.75 %) |
Sep 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.70 | 10,000 | 37,000 | 216,541 | 226.5 K to 216.5 K (-4.41 %) |
Sep 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.69 | 10,000 | 36,900 | 226,541 | 236.5 K to 226.5 K (-4.23 %) |
Sep 02 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.53 | 9,000 | 31,770 | 254,701 | 263.7 K to 254.7 K (-3.41 %) |
Sep 01 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.58 | 3,011 | 10,779 | 263,701 | 266.7 K to 263.7 K (-1.13 %) |
Sep 02 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.53 | 6,000 | 21,180 | 236,541 | 242.5 K to 236.5 K (-2.47 %) |
Sep 01 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.58 | 2,000 | 7,160 | 242,541 | 244.5 K to 242.5 K (-0.82 %) |
Aug 31 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.55 | 15,000 | 53,250 | 266,712 | 281.7 K to 266.7 K (-5.32 %) |
Aug 31 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.55 | 10,000 | 35,500 | 244,541 | 254.5 K to 244.5 K (-3.93 %) |
Aug 30 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.67 | 6,177 | 22,670 | 281,712 | 287.9 K to 281.7 K (-2.15 %) |
Aug 30 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.70 | 1,600 | 5,920 | 287,889 | 289.5 K to 287.9 K (-0.55 %) |
Aug 30 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.67 | 18,823 | 69,080 | 254,541 | 273.4 K to 254.5 K (-6.89 %) |
Aug 30 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.70 | 1,000 | 3,700 | 273,364 | 274.4 K to 273.4 K (-0.36 %) |
Aug 27 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.60 | 33,000 | 118,800 | 274,364 | 307.4 K to 274.4 K (-10.74 %) |
Aug 27 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.65 | 5,310 | 19,382 | 307,364 | 312.7 K to 307.4 K (-1.70 %) |
Aug 25 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.60 | 17,000 | 61,200 | 312,674 | 329.7 K to 312.7 K (-5.16 %) |
Aug 25 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.61 | 100 | 361 | 329,674 | 329.8 K to 329.7 K (-0.03 %) |
Aug 24 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT INTERNATIONAL L P | Director | Sell | S | 3.50 | 42,859 | 150,007 | 289,489 | 332.3 K to 289.5 K (-12.90 %) |
Aug 24 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.60 | 3,390 | 12,204 | 329,774 | 333.2 K to 329.8 K (-1.02 %) |
Aug 24 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.50 | 121,141 | 423,994 | 333,164 | 454.3 K to 333.2 K (-26.67 %) |